2. SPECIAL (GAINS) AND CHARGES

​

Special (gains) and charges reported on the Consolidated Statements of Income include the following:

​

​

For segment reporting purposes, special (gains) and charges are not allocated to reportable segments, which is consistent with the Company’s internal management reporting.

​

One Ecolab

​

On July 30, 2024, the Company announced the One Ecolab initiative, which will enhance its growth and margin expansion journey. As a program within this initiative, the Company also announced that it commenced a restructuring plan to leverage its digital technologies to realign the functional work done in many countries into global centers of excellence. In February 2026, the Company expanded the One Ecolab initiative and anticipates total restructuring costs of $328 million ($256 million after tax) and special charges of $97 million ($76 million after tax) by the end of 2027. The Company anticipates that the restructuring costs will primarily be cash expenditures for severance costs relating to team reorganization.

​

The Company recorded restructuring charges of $27.5 million ($20.6 million after tax) and $39.4 million ($30.5 million after tax) during the first quarter of 2026 and 2025, respectively, primarily related to severance and professional services. In addition, the Company recorded non-restructuring special charges of $5.5 million ($4.2 million after tax) and $4.8 million ($3.6 million after tax) during the first quarter of 2026 and 2025, respectively, primarily related to professional services. The Company has recorded $226.3 million ($174.1 million after tax) of cumulative restructuring charges and $60.1 million ($45.5 million after tax) of cumulative special charges under the One Ecolab initiative.

​

The net restructuring liability related to the One Ecolab initiative was $91.0 million and $96.1 million as of March 31, 2026 and December 31, 2025, respectively. The remaining liability is expected to be paid over a period of a few months to several quarters and will continue to be funded from operating activities.

​

​

Restructuring activity related to the One Ecolab initiative since inception of the underlying actions includes the following items:

​

​

Other restructuring

​

Other restructuring is primarily related to other immaterial restructuring programs. These activities have been included as a component of cost of sales and special (gains) and charges on the Consolidated Statements of Income. Restructuring liabilities have been classified as a component of other current and other noncurrent liabilities on the Consolidated Balance Sheets.

​

During the first quarter of 2026, the Company recorded $9.7 million ($7.8 million after tax) related to other immaterial restructuring programs.

​

The restructuring liability balance for all other restructuring plans excluding One Ecolab was $11.8 million and $8.8 million as of March 31, 2026 and December 31, 2025, respectively. The remaining liability is expected to be paid over a period of a few months to several quarters and will continue to be funded from operating activities.

​

Acquisition and integration related costs

​

Acquisition and integration related costs reported in special (gains) and charges on the Consolidated Statements of Income include $14.1 million ($12.3 million after tax) and $1.5 million ($1.1 million after tax) in the first quarter of 2026 and 2025, respectively, primarily related to the Ovivo Electronics and pending CoolIT Systems acquisitions.

​

Sale of global surgical solutions business

On April 27, 2024, the Company reached a definitive agreement to sell its global surgical solutions business, which closed on August 1, 2024. The Company recorded charges of $1.6 million ($1.2 million after tax) in the first quarter of 2025.

​

Other operating activities

​

Other special charges recorded in special (gains) and charges on the Consolidated Statements of Income in the first quarter of 2026 were $0.9 million ($0.6 million after tax). Other special gains recorded in special (gains) and charges in the first quarter of 2025 were $13.0 million ($11.3 million gain after tax), primarily related to the sale of an equity method investment.